PremiumCompany AnnouncementsStaar Surgical to Present Strategic Plans to Investors Cautious Hold Rating on Staar Surgical Amid Modest Improvements in Chinese Market STAAR Surgical Announces $30 Million Share Buyback PremiumThe FlyStaar Surgical price target raised to $20 from $17 at Canaccord Cautious Outlook on Staar Surgical Amid Market Challenges and Guidance Withdrawal STAAR Surgical Faces Challenges, Eyes Future Growth PremiumCompany AnnouncementsStaar Surgical Announces Board Changes and New Advisor Staar Surgical initiated with an Equal Weight at Wells Fargo Staar Surgical Announces Leadership Realignment for Growth 
